組換えタンパク質市場レポート：2023-2033

Recombinant Proteins Market Report 2023-2033

レポート詳細組換えタンパク質市場レポート 2023-2033 ：本レポートは、業界とその基礎となる力学をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2023年4月20日	GBP4,500 部署ライセンスライセンス・価格情報注文方法はこちら	353	394	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

目次
図表リスト

サマリー

レポート詳細

組換えタンパク質市場レポート 2023-2033：本レポートは、業界とその基礎となる力学をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有益なレポートです。

慢性疾患の有病率や発症率の上昇、技術革新、主要企業による研究開発投資の拡大が、組換えタンパク質市場の成長を促進する主な要因となっています。一般市民や政府における慢性疾患に対する意識の高まりは、組換え商品の市場を改善すると予測されます。世界保健機関（WHO）によると、慢性疾患は世界の死亡原因の60％以上を占める主要なものです。

慢性疾患の頻度の増加は、市場に影響を与える大きな要因の一つです。糖尿病、がん、呼吸器疾患、心血管疾患は、最も一般的な慢性疾患のほんの一握りに過ぎません。Globocanの予測によると、がんの患者数は2020年の1930万人から2030年には2460万人に増加するとされています。さらに、2030年には、全世界で5億8700万人の糖尿病患者が発生すると言われています。中低所得国では、慢性疾患が死亡率の80％以上を占めています。米国では、2025年までに人口の49％以上が慢性疾患にかかると予想されています。米国では、脳卒中と心臓病が死亡原因の30％を占めています。

マーケットリサーチレポートを購入する前に、どのような質問をするべきか？
- 組換えタンパク質市場はどのように進化しているのか？
- 組換えタンパク質市場を牽引し、抑制しているものは何か？
- 組換えタンパク質の各サブマーケットセグメントは予測期間中にどのように成長し、2033年にこれらのサブマーケットが占める売上はどの程度になるのか？
- 2023年から2033年にかけて、組換えタンパク質の各サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて、市場全体の主な牽引役となるのは何か？
- 組換えタンパク質の主要市場は、マクロ経済ダイナミクスに広く追随するのか、それとも個々の国別市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しはどうなのか？
- これらの主要企業の組換えタンパク質のプロジェクトは何か？
- 2023年から2033年の間に、業界はどのように進化していくのか？現在および今後10年間に行われる組換えタンパク質のプロジェクトには、どのような意味があるのでしょうか？
- 組換えタンパク質市場をさらに拡大するために、製品の商業化の必要性は高まっているのか？
- 組換えタンパク質市場はどこに向かっているのか、そして市場の最前線に立つためにはどうすればよいのか？
- 新製品やサービスラインへの最適な投資方法は何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望は何か？

このことが、現在、そして今後10年間の組換えタンパク質市場にどのような影響を与えるかを見極める必要があります：
- 353ページにわたる本レポートでは、146の表と248のチャート/グラフを独占的に提供します。
- 本レポートでは、業界における主要な収益性の高い分野を取り上げているため、今すぐその分野をターゲットにすることができます。
- 世界、地域、国の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。

本レポートは、組換えタンパク質市場が今後10年間にどのように発展していくか、またCOVID-19の景気後退や景気回復の変動に合わせて、今日あなたにお伝えします。この市場は、過去10年間のどの時点よりも今が重要です。

2033年までの予測やその他の分析により、商業的な展望を明らかにする。
- 今回の調査では、2033年までの収益予測に加え、直近の実績、成長率、市場シェアも掲載しています。
- ビジネスの展望や展開など、独自の分析がご覧いただけます。
- 定性的分析（市場力学、促進要因、機会、阻害要因、課題など）、コスト構造、組換えタンパク質の価格上昇の影響、最近の動向などをご覧いただけます。

本レポートでは、COVID-19が業界や貴社にどのような影響を与えるかについて、データ分析および貴重な知見を提供しています。COVID-19の4つの回収パターン、すなわち「V」「L」「W」「U」の回収パターンとその影響について考察しています。

報告書の対象セグメント

製品・サービス展望
・製品
- サイトカインと成長因子：インターフェロン（IFNs）、インターロイキン（ILs）、その他
- 抗体
- 酵素キナーゼ酵素、代謝酵素、その他
- 組換えレギュラトリータンパク質
- ホルモン
- ウイルス抗原
- 免疫チェックポイント蛋白質
- その他
・サービス

用途展望
・バイオ医薬品の製造
- 生物製剤
- ワクチン
- 細胞・遺伝子治療薬
- その他
・創薬・医薬品開発
・研究開発
・診断薬
・その他

宿主細胞展望
- 哺乳類系
- 細菌細胞
- 酵母・菌類
- 昆虫細胞
- その他

エンドユーザー展望
- バイオ医薬品・バイオテクノロジー企業
- CROs
- 学術・研究機関
- 診断ラボラトリー
- その他

世界市場全体およびセグメントの収益予測に加え、5つの地域および18の主要国市場の収益予測も掲載しています：

北米
- 米国
- カナダ

欧州
- ドイツ
- イギリス
- フランス
- スペイン
- イタリア
- ロシア
- その他の欧州地域

アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他のラテンアメリカ地域

MEA
- GCC
- 南アフリカ
- その他のMEA地域

また、組換えタンパク質市場の2023年から2033年にかけての主要企業のプロファイルと、これらの企業のこのセグメントに焦点を当てたいくつかの企業についても記載しています。

主要企業と市場成長の可能性
・ Abcam Plc
・ Abnova Corporation
・ Avantor Inc.
・ Bio-Rad Laboratories, Inc.
・ Bio-Techne
・ Enzo Biochem Inc.
・ GenScript
・ Merck KGaA
・ PerkinElmer, Inc.
・ Proteintech Group, Inc.
・ RayBiotech Life, Inc.
・ Sino Biological Inc.
・ STEMCELL Technologies
・ Thermo Fisher Scientific Inc.

組換えタンパク質市場の世界全体の収益、2023年から2033年までの金額ベースで、2023年に3,079.9百万米ドルを突破すると、当研究所が算出しました。2033年まで収益が大きく伸びることが予測されます。当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的な展望を発見し、あなたが一歩先を行くのを支援します。

組換えタンパク質市場、2023年から2033年までのレポートはどのように役立つのでしょうか？
要約すると、350ページ以上のレポートでは、以下のような知識を得ることができます：

- 組換えタンパク質市場、2023年から2033年までの収益予測製品＆サービス、アプリケーション、宿主細胞、エンドユーザー、それぞれの予測を世界と地域レベルで掲載 - 業界の展望を発見し、投資と収益のための最も有利な場所を見つけることができます。

- 5つの地域と22の主要国市場の2033年までの収益予測 - 組換えタンパク質市場、2023年から2033年の北米、欧州、アジア太平洋、ラテンアメリカ、MEAの市場予測をご覧いただけます。また、アメリカ、カナダ、メキシコ、ブラジル、ドイツ、フランス、イギリス、イタリア、中国、インド、日本、オーストラリアなど、著名な経済圏の市場も予測されています。

- 組換えタンパク質市場に関わる主要企業14社の企業プロファイルを含む、2023年から2033年までの既存企業および市場参入を目指す企業の展望。

独自の予測による定量・定性分析をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスとして情報を得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性は低くなります。私たちの仕事があなたの研究、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、組換えタンパク質市場、2023年から2033年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測を見つけることができます。

ページTOPに戻る

1 レポート概要
1.1 研究の目的
1.2 組換えタンパク質市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な疑問点
1.6 本レポートは誰のためのものなのか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの妥当性確認
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問(FAQ)
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 市場概要
3.1 主要な調査結果
3.2 マーケットダイナミクス
3.2.1 市場促進要因
3.2.1.1 リコンビナント製品への需要の高まり
3.2.1.2 バイオメディカル研究への高い資金援助
3.2.1.3 高齢者人口の増加が市場成長を促進する
3.2.1.4 生物学的製剤の特許切れ
3.2.2 市場抑制要因
3.2.2.1 組換えタンパク質の価格侵食
3.2.2.2 組換えタンパク質の生産に対する厳しい規制
3.2.3 市場機会
3.2.3.1 新興国における研究開発の拡大および優先順位付け
3.2.3.2 ゲノミクスとプロテオミクスの重要性の増加
3.3 COVID-19影響度分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーのバーゲニングパワー
3.4.2 バイヤーのバーゲニングパワー
3.4.3 競合他社のライバル関係
3.4.4 代替品による脅威
3.4.5 新規参入の脅威
3.5 PEST分析
3.5.1 組換えタンパク質市場に影響を与える政治的要因
3.5.2 組換えタンパク質市場に影響を与える経済的要因
3.5.3 組換えタンパク質市場に影響を与える社会的要因
3.5.4 組換えタンパク質市場に影響を与える技術的要因

4 組換えタンパク質の市場分析：製品・サービス別
4.1 主要な調査結果
4.2 製品・サービスセグメント別市場魅力度指数
4.3 組換えタンパク質の製品・サービス別市場規模の推定と予測
4.4 製品
4.4.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
4.4.2 2023年および2033年の地域別市場シェア (%)
4.4.3 サイトカインおよび成長因子
4.4.3.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
4.4.3.2 2023年および2033年の地域別市場シェア (%)
4.4.3.3 インターフェロン（IFNs)
4.4.3.4 インターロイキン(IL)
4.4.3.5 その他
4.4.4 抗体
4.4.4.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
4.4.4.2 2023年および2033年の地域別市場シェア (%)
4.4.5 酵素
4.4.5.1 酵素の地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
4.4.5.2 2023年および2033年の地域別市場シェア（%)
4.4.5.3 キナーゼ酵素
4.4.5.4 代謝酵素
4.4.5.5その他の酵素
4.4.6 組換え制御タンパク質
4.4.6.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
4.4.6.2 2023年および2033年の地域別市場シェア(%)
4.4.7 ホルモン
4.4.7.1 ホルモンの地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
4.4.7.2 2023年および2033年の地域別市場シェア(%)
4.4.8 ウイルス抗原
4.4.8.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
4.4.8.2 2023年および2033年の地域別市場シェア (%)
4.4.9 免疫チェックポイント蛋白質
4.4.9.1 地域別市場規模、2023年～2033年（US$ Million, AGR%, CAGR%)
4.4.9.2 2023年および2033年の地域別市場シェア（%)
4.4.10 その他
4.4.10.1 地域別市場規模、2023-2033年（US$ Million、AGR%、CAGR%)
4.4.10.2 2023年および2033年の地域別市場シェア (%)
4.5 サービス
4.5.1 サービスの地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
4.5.2 2023年および2033年の地域別市場シェア (%)

5 組換えタンパク質市場分析：用途別
5.1 主要な調査結果
5.2 用途別セグメント市場魅力度指数
5.3 組換えタンパク質の用途別市場規模の推定と予測
5.4 バイオ医薬品の生産量
5.4.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
5.4.2 2023年および2033年の地域別市場シェア (%)
5.4.3 バイオロジクス
5.4.3.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
5.4.3.2 2023年および2033年の地域別市場シェア (%)
5.4.4 ワクチン
5.4.4.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
5.4.4.2 2023年および2033年の地域別市場シェア (%)
5.4.5 細胞・遺伝子治療薬
5.4.5.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
5.4.5.2 2023年および2033年の地域別市場シェア (%)
5.4.6 その他
5.4.6.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
5.4.6.2 2023年および2033年の地域別市場シェア (%)
5.5 創薬・開発
5.5.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
5.5.2 2023年および2033年の地域別市場シェア (%)
5.6 リサーチ
5.6.1 研究分野の地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
5.6.2 地域別市場シェア、2023年および2033年 (%)
5.7 診断薬
5.7.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
5.7.2 地域別市場シェア、2023年および2033年 (%)
5.8 その他
5.8.1 その他の地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
5.8.2 地域別市場シェア、2023年および2033年 (%)

6 組換えタンパク質市場分析：宿主細胞別
6.1 主要な調査結果
6.2 宿主細胞セグメント市場魅力度指数
6.3 宿主細胞別の組換えタンパク質市場規模の推定と予測
6.4 哺乳類システム
6.4.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
6.4.2 2023年および2033年の地域別市場シェア (%)
6.5 バクテリア細胞
6.5.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
6.5.2 2023年および2033年の地域別市場シェア (%)
6.6 酵母・菌類
6.6.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
6.6.2 2023年および2033年の地域別市場シェア (%)
6.7 昆虫細胞
6.7.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
6.7.2 2023年および2033年の地域別市場シェア (%)
6.8 その他
6.8.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
6.8.2 2023年および2033年の地域別市場シェア (%)

7 組換えタンパク質市場分析：エンドユーザー別
7.1 主要な調査結果
7.2 組換えタンパク質のエンドユーザー別市場規模の推定と予測
7.3 バイオ医薬品・バイオテクノロジー企業
7.3.1 バイオ医薬品およびバイオテクノロジー企業の地域別市場規模、2023-2033年（US$ Million, AGR%, CAGR%)
7.3.2 2023年および2033年の地域別市場シェア (%)
7.4 CROs
7.4.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
7.4.2 2023年および2033年の地域別市場シェア (%)
7.5 アカデミック＆リサーチ・インスティチュート
7.5.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
7.5.2 2023年および2033年の地域別市場シェア (%)
7.6 診断ラボラトリー
7.6.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
7.6.2 2023年および2033年の地域別市場シェア(%)
7.7 その他
7.7.1 地域別市場規模、2023-2033年（US$ Million、AGR%, CAGR%)
7.7.2 2023年および2033年の地域別市場シェア(%)

8 組換えタンパク質市場分析：地域別
8.1 主要な調査結果
8.2 地域別市場規模の推計と予測

9 北米の組換えタンパク質市場分析
9.1 主要な発見
9.2 北米の組換えタンパク質市場魅力度指数
9.3 北米の組換えタンパク質市場：国別、2023年、2028年、2033年 (US$ Mn)
9.4 北米の組換えタンパク質の国別市場規模推定と予測
9.5 北米の組換えタンパク質市場規模推定と予測：製品・サービス別
9.6 北米の組換えタンパク質の市場規模推定と予測：製品タイプ別
9.7 北米の組換えタンパク質の市場規模推定と予測：サイトカイン・成長因子タイプ別
9.8 北米の組換えタンパク質の市場規模推定と予測：酵素タイプ別
9.9 北米の組換えタンパク質の市場規模推定と予測：用途別
9.10 北米の組換えタンパク質の市場規模推定と予測：バイオ医薬品生産タイプ別
9.11 北米の組換えタンパク質の市場規模推定と予測：エンドユーザー別
9.12 北米の組換えタンパク質の市場規模推定と予測：宿主細胞別
9.13 米国組換えタンパク質の市場分析
9.14 カナダ組換えタンパク質の市場分析

10 欧州の組換えタンパク質市場分析
10.1 主要な調査結果
10.2 欧州の組換えタンパク質市場魅力度指数
10.3 欧州の組換えタンパク質市場：国別、2023年、2028年、2033年 (US$ Mn)
10.4 欧州の組換えタンパク質の国別市場規模推定と予測
10.5 欧州の組換えタンパク質の市場規模推定と予測：製品・サービス別
10.6 欧州の組換えタンパク質の市場規模推定と予測：製品タイプ別
10.7 欧州の組換えタンパク質の市場規模推定と予測：サイトカイン・成長因子タイプ別
10.8 欧州の組換えタンパク質の市場規模推定と予測：酵素タイプ別
10.9 欧州の組換えタンパク質の市場規模推定と予測：用途別
10.10 欧州の組換えタンパク質の市場規模推定と予測：バイオ医薬品生産タイプ別
10.11 欧州の組換えタンパク質の市場規模推定・予測：エンドユーザー別
10.12 欧州の組換えタンパク質の市場規模予測・予測：宿主細胞別
10.13 ドイツ組換えタンパク質市場分析
10.14 イギリス組換えタンパク質市場の分析
10.15 フランス組換えタンパク質の市場分析
10.16 イタリア組換えタンパク質市場の分析
10.17 スペイン組換えタンパク質市場の分析
10.18 ロシア組換えタンパク質市場の分析
10.19 その他の欧州の組換えタンパク質の市場分析

11 アジア太平洋地域の組換えタンパク質市場分析
11.1 主要な調査結果
11.2 アジア太平洋地域の組換えタンパク質市場魅力度指数
11.3 アジア太平洋地域の組換えタンパク質市場：国別、2023年、2028年、2033年 (US$ Mn)
11.4 アジア太平洋地域の組換えタンパク質の国別市場規模推計と予測
11.5 アジア太平洋地域の組換えタンパク質の市場規模推定と予測：製品・サービス別
11.6 アジア太平洋地域の組換えタンパク質の市場規模推定と予測：製品タイプ別
11.7 アジア太平洋地域の組換えタンパク質の市場規模推定と予測：サイトカイン・成長因子タイプ別
11.8 アジア太平洋地域の組換えタンパク質の市場規模推定と予測：酵素タイプ別
11.9 アジア太平洋地域の組換えタンパク質の市場規模推定と予測：用途別
11.10 アジア太平洋地域の組換えタンパク質の市場規模推定と予測：バイオ医薬品生産タイプ別
11.11 アジア太平洋地域の組換えタンパク質の市場規模推定と予測：宿主細胞別
11.12 アジア太平洋地域の組換えタンパク質の市場規模推定と予測：エンドユーザー別
11.13 日本組換えタンパク質の市場分析
11.14 中国組換えタンパク質の市場分析
11.15 インド組換えタンパク質市場の分析
11.16 オーストラリア組換えタンパク質市場の分析
11.17 韓国組換えタンパク質市場の分析
11.18 その他のアジア太平洋地域の組換えタンパク質の市場分析

12 ラテンアメリカ組換えタンパク質市場分析
12.1 主要な調査結果
12.2 ラテンアメリカの組換えタンパク質市場魅力度指数
12.3 ラテンアメリカの組換えタンパク質市場：国別、2023年、2028年、2033年 (US$ Mn)
12.4 ラテンアメリカの組換えタンパク質の製品・サービス別市場規模の推定と予測
12.5 ラテンアメリカの組換えタンパク質の市場規模推定と予測：製品タイプ別
12.6 ラテンアメリカの組換えタンパク質の市場規模推定と予測：サイトカイン・成長因子タイプ別
12.7 ラテンアメリカの組換えタンパク質の市場規模推定と予測：酵素タイプ別
12.8 ラテンアメリカの組換えタンパク質の市場規模推定・予測：用途別
12.9 ラテンアメリカの組換えタンパク質の市場規模推定と予測：バイオ医薬品生産タイプ別
12.10 ラテンアメリカの組換えタンパク質の市場規模推定と予測：エンドユーザー別
12.11 ラテンアメリカの組換えタンパク質の市場規模推定と予測：宿主細胞別
12.12 ブラジル組換えタンパク質の市場分析
12.13 メキシコ組換えタンパク質の市場分析
12.14 アルゼンチン組換えタンパク質の市場分析
12.15 その他のラテンアメリカの組換えタンパク質の市場分析

13 MEAの組換えタンパク質市場分析
13.1 主要な調査結果
13.2 MEAの組換えタンパク質市場魅力度指数
13.3 MEAの組換えタンパク質の国別市場：2023年、2028年、2033年 (US$ Mn)
13.4 MEAの組換えタンパク質の国別市場規模推計と予測
13.5 MEAの組換えタンパク質の市場規模推定と予測：製品・サービス別
13.6 MEAの組換えタンパク質の市場規模推定と予測：製品タイプ別
13.7 MEAの組換えタンパク質の市場規模推定と予測：サイトカイン・成長因子タイプ別
13.8 MEAの組換えタンパク質の市場規模推定と予測：酵素タイプ別
13.9 MEAの組換えタンパク質の市場規模推定・予測：用途別
13.10 MEAの組換えタンパク質の市場規模推定と予測：バイオ医薬品生産タイプ別
13.11 MEAの組換えタンパク質の市場規模推定と予測：エンドユーザー別
13.12 MEAの組換えタンパク質の市場規模推定と予測：エンドユーザー別
13.13 GCC組換えタンパク質の市場分析
13.14 南アフリカの組換えタンパク質市場の分析
13.15 その他のMEAの組換えタンパク質の市場分析

14 会社概要
14.1 競合状況、2022年
14.2 Abcam plc
14.2.1 企業スナップショット
14.2.2 会社概要
14.2.3 財務分析
14.2.3.1 純収益、2017年～2022年
14.2.3.2 地域別市場占有率、2022年
14.2.4 製品ベンチマーキング
14.2.5 戦略的な展望
14.3 Bio-Techne
14.3.1 企業スナップショット
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 純収益、2017-2022年
14.3.3.2 研究開発、2017年～2022年
14.3.3.3 地域別市場シェア、2022年
14.3.3.4 セグメント別市場シェア、2022年
14.3.4 製品のベンチマーキング
14.3.5 戦略的な展望
14.4 GenScript
14.4.1 企業スナップショット
14.4.2 会社概要
14.4.3 財務分析
14.4.3.1 純収益、2017年〜2022年
14.4.3.2 地域別市場シェア、2022年
14.4.3.3 セグメント別市場シェア、2021年
14.4.4 製品のベンチマーキング
14.5 Bio-Rad Laboratories, Inc.
14.5.1 企業スナップショット
14.5.2 会社概要
14.5.3 財務分析
14.5.3.1 純収益、2017年〜2022年
14.5.3.2 地域別市場シェア、2022年
14.5.3.3 セグメント別市場シェア、2022年
14.5.4 製品ベンチマーキング
14.5.5 戦略的な展望
14.6 Merck KGaA
14.6.1 企業スナップショット
14.6.2 会社概要
14.6.3 財務分析
14.6.3.1 純収益、2017-2022年
14.6.3.2 研究開発、2017年〜2022年
14.6.3.3 地域別市場シェア、2022年
14.6.3.4 セグメント別市場シェア、2022年
14.6.4 製品のベンチマーキング
14.7 Thermo Fisher Scientific
14.7.1 企業スナップショット
14.7.2 会社概要
14.7.3 財務分析
14.7.3.1 純収益、2017-2022年
14.7.3.2 研究開発費、2017年～2022年
14.7.3.3 地域別市場シェア、2022年
14.7.3.4 セグメント別市場シェア、2022年
14.7.4 製品のベンチマーキング
14.7.5 戦略的な展望
14.8 Enzo Biochem Inc.
14.8.1 企業スナップショット
14.8.2 会社概要
14.8.3 財務分析
14.8.3.1 純収益、2017-2022年
14.8.3.2 研究開発、2017年-2022年
14.8.3.3 地域別市場シェア、2022年
14.8.3.4 セグメント別市場シェア、2022年
14.8.4 製品のベンチマーキング
14.9 Sino Biological, Inc.
14.9.1 企業スナップショット
14.9.2 会社概要
14.9.3 製品ベンチマーク
14.10 Proteintech Group, Inc
14.10.1 カンパニースナップショット
14.10.2 会社概要
14.10.3 製品ベンチマーキング
14.11 Abnova Corporation
14.11.1 企業スナップショット
14.11.2 会社概要
14.11.3 製品ベンチマーク
14.12 RayBiotech Life, Inc.
14.12.1 企業スナップショット
14.12.2 会社概要
14.12.3 製品ベンチマーク
14.13 STEMCELL Technologies
14.13.1 カンパニースナップショット
14.13.2 会社概要
14.13.3 ベンチマーキング製品
14.14 PerkinElmer Inc.
14.14.1 企業スナップショット
14.14.2 会社概要
14.14.3 財務分析
14.14.3.1 純収益、2017-2022年
14.14.3.2 研究＆開発、2017年〜2022年
14.14.3.3 地域別市場シェア、2022年
14.14.3.4 セグメント別市場シェア、2022年
14.14.4 製品のベンチマーキング
14.14.5 戦略的な展望
14.15 Avantor Inc.
14.15.1 企業スナップショット
14.15.2 会社概要
14.15.3 財務分析
14.15.3.1 純収益、2017年〜2022年
14.15.3.2 地域別市場占有率、2022年
14.15.4 製品のベンチマーキング
14.15.5 戦略的な展望

15 結論と提言
15.1 Visiongainからの結びの言葉
15.2 市場関係者への提言

ページTOPに戻る

図表リスト

表の一覧
Table 1 Recombinant Proteins Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Product Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Cytokines & Growth Factors Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Interferons (IFNs)Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Interleukins (ILs) Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Antibodies Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Kinases Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Metabolic Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Other Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Recombinant Regulatory Protein Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Hormones Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Virus Antigens Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Immune Checkpoint Proteins Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Service Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Biopharmaceutical production Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Biologics Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Cell & Gene Therapies Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Drug Discovery & Development Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Research Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Diagnostics Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Mammalian Systems Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Bacterial Cells Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Yeast & Fungi Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Insect Cells Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Biopharmaceutical and Biotechnology Companies Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 CROs Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Academic & Research Institutes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Diagnostic Laboratories Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Recombinant Proteins Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 46 North America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 North America Recombinant Proteins Market Forecast by Product &Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 North America Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 North America Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 North America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 North America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 North America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 North America Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 North America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 U.S. Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Canada Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Europe Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Europe Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Europe Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Europe Recombinant Proteins Market Forecast by Cytokines & Growth Factors, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Europe Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Europe Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Europe Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Europe Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Europe Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Germany Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 UK Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 France Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 Italy Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 Spain Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 Russia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 Rest of Europe Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 Asia Pacific Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Asia Pacific Recombinant Proteins Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Asia Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 Asia Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 Asia Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 78 Asia Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 79 Asia-Pacific Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 80 Asia Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 81 Asia Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 82 Japan Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 83 China Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 84 India Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 85 Australia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 86 South Korea Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 87 Rest of Asia Pacific Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 88 Latin America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 89 Latin America Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 90 MEA Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 91 Latin America Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 92 Latin America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 93 Latin America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 94 Latin America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 95 Latin America Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 96 Latin America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 97 Brazil Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 98 Mexico Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 99 Argentina Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 100 Rest of Latin America Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 101 MEA Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 102 MEA Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 103 MEA Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 104 MEA Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 105 MEA Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 106 MEA Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 107 MEA Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 108 MEA Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 109 MEA Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 110 GCC Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 111 South Africa Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 112 Rest of MEA Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 113 Abcam plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Abcam plc: Product Benchmarking
Table 115 Abcam plc: Strategic Outlook
Table 116 Bio-Techne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Bio-Techne.: Product Benchmarking
Table 118 Bio-Techne.: Strategic Outlook
Table 119 GenScript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 GenScript: Product Benchmarking
Table 121 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Bio-Rad Laboratories, Inc.: Product Benchmarking
Table 123 Bio-Rad Laboratories, Inc.: Strategic Outlook
Table 124 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Merck KGaA: Product Benchmarking
Table 126 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Thermo Fisher Scientific: Product Benchmarking
Table 128 Thermo Fisher Scientific: Strategic Outlook
Table 129 Enzo Biochem Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Enzo Biochem Inc.: Product Benchmarking
Table 131 Sino Biological, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Sino Biological, Inc.: Product Benchmarking
Table 133 Proteintech Group, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Proteintech Group, Inc: Product Benchmarking
Table 135 Abnova Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Abnova Corporation: Product Benchmarking
Table 137 RayBiotech Life, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 RayBiotech Life, Inc.: Product Benchmarking
Table 139 STEMCELL Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 STEMCELL Technologies: Product Benchmarking
Table 141 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 PerkinElmer Inc.: Product Benchmarking
Table 143 PerkinElmer Inc.: Strategic Outlook
Table 144 Avantor Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 Avantor Inc.: Product Benchmarking
Table 146 Avantor Inc.: Strategic Outlook

図の一覧
Figure 1 Recombinant Proteins Market Segmentation
Figure 2 Recombinant Proteins Market by Products: Market Attractiveness Index
Figure 3 Recombinant Proteins Market Attractiveness Index by Region
Figure 4 Recombinant Proteins Market: Market Dynamics
Figure 5 NIH Program Level Budget
Figure 6 Global Population Aged 65+, 2022 (Unit Million)
Figure 7 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Recombinant Proteins Market: Porter’s Five Forces Analysis
Figure 12 Recombinant Proteins Market: PEST Analysis
Figure 13 Recombinant Proteins Market Forecast by Product & Services Market Attractiveness Index
Figure 14 Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million)
Figure 15 Recombinant Proteins Market Share Forecast by Product & Services, 2023, 2028, 2033 (%)
Figure 16 Product Market Forecast by Region, 2022-2033 (US$ Million)
Figure 17 Product Market Share Forecast by Region, 2023 & 2033 (%)
Figure 18 Cytokines & Growth Factors Market Forecast by Region, 2023-2033 (US$ Million)
Figure 19 Cytokines & Growth Factors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Interferons (IFNs) Market Forecast by Region, 2023-2033 (US$ Million)
Figure 21 Interferons (IFNs) Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 interleukins (ILs)Market Forecast by Region, 2023-2033 (US$ Million)
Figure 23 interleukins (ILs)Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 25 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Antibodies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 27 Antibodies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Enzymes Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Enzymes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Kinase Enzyme Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Kinase Enzyme Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Metabolic Enzyme Market Forecast by Region, 2023-2033 (US$ Million)
Figure 33 Metabolic Enzyme Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Other Enzyme Market Forecast by Region, 2023-2033 (US$ Million)
Figure 35 Other Enzyme Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Recombinant Regulatory Protein Market Forecast by Region, 2023-2033 (US$ Million)
Figure 37 Recombinant Regulatory Protein Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Hormones Market Forecast by Region, 2023-2033 (US$ Million)
Figure 39 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Virus Antigens Market Forecast by Region, 2023-2033 (US$ Million)
Figure 41 Virus Antigens Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Immune Checkpoint Proteins Market Forecast by Region, 2023-2033 (US$ Million)
Figure 43 Immune Checkpoint Proteins Market Share Forecast by Region, 2023 & 2033 (%)
Figure 44 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 45 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 46 Services Market Forecast by Region, 2023-2033 (US$ Million)
Figure 47 Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 48 Recombinant Proteins Market Forecast by Application 2023, 2028, 2033 (Revenue, CAGR%)
Figure 49 Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 50 Recombinant Proteins Market Share Forecast by Application 2023, 2028, 2033 (%)
Figure 51 Biopharmaceutical Production Market Forecast by Region, 2023-2033 (US$ Million)
Figure 52 Biopharmaceutical production Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Biologics Market Forecast by Region, 2023-2033 (US$ Million)
Figure 54 Biologics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 55 Vaccines Market Forecast by Region, 2023-2033 (US$ Million)
Figure 56 Vaccines Market Share Forecast by Region, 2023 & 2033 (%)
Figure 57 Cell & Gene Therapy Market Forecast by Region, 2023-2033 (US$ Million)
Figure 58 Cell & Gene Therapy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 59 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 60 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 61 Drug Discovery & Development Market Forecast by Region, 2023-2033 (US$ Million)
Figure 62 Drug Discovery & Development Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 Research Market Forecast by Region, 2023-2033 (US$ Million)
Figure 64 Research Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Diagnostics Market Forecast by Region, 2023-2033 (US$ Million)
Figure 66 Diagnostics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 68 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 69 Recombinant Proteins Market Forecast by Host Cell 2023, 2028, 2033 (Revenue, CAGR%)
Figure 70 Recombinant Proteins Market Forecast by Host Cells, 2023-2033 (US$ Million)
Figure 71 Recombinant Proteins Market Share Forecast by Host Cells, 2023, 2028, 2033 (%)
Figure 72 Mammalian System Market Forecast by Region, 2023-2033 (US$ Million)
Figure 73 Mammalian System Market Share Forecast by Region, 2023 & 2033 (%)
Figure 74 Bacterial Cells Market Forecast by Region, 2023-2033 (US$ Million)
Figure 75 Bacterial Cells Market Share Forecast by Region, 2023 & 2033 (%)
Figure 76 Yeast and Fungi Market Forecast by Region, 2023-2033 (US$ Million)
Figure 77 Yeast & Fungi Market Share Forecast by Region, 2023 & 2033 (%)
Figure 78 Insect Cells Market Forecast by Region, 2023-2033 (US$ Million)
Figure 79 Insect Cells Market Share Forecast by Region, 2023 & 2033 (%)
Figure 80 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 81 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 82 Recombinant Proteins Market Forecast by Therapeutics, 2023-2033 (US$ Million)
Figure 83 Recombinant Proteins Market Share Forecast by Therapeutics, 2023, 2028, 2033 (%)
Figure 84 Biopharmaceutical and Biotechnology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 85 Biopharmaceutical and Biotechnology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 86 CROs Market Forecast by Region, 2023-2033 (US$ Million)
Figure 87 CROs Market Share Forecast by Region, 2023 & 2033 (%)
Figure 88 Research Market Forecast by Region, 2023-2033 (US$ Million)
Figure 89 Academic & Research Institutes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 90 Diagnostics Laboratories Market Forecast by Region, 2023-2033 (US$ Million)
Figure 91 Diagnostics Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
Figure 92 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 93 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 94 Recombinant Proteins Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 95 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Figure 96 North America Recombinant Proteins Market Attractiveness Index
Figure 97 North America Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 98 North America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 99 North America Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 100 North America Recombinant Proteins Market Forecast by Products and Services, 2023-2033 (US$ Million)
Figure 101 North America Recombinant Proteins Market Share Forecast by Products and Services, 2023 & 2033 (%)
Figure 102 North America Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 103 North America Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 104 North America Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million)
Figure 105 North America Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors Type, 2023 & 2033 (%)
Figure 106 North America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 107 North America Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 108 North America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 109 North America Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 110 North America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 111 North America Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 112 North America Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million)
Figure 113 North America Recombinant Proteins Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 114 North America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 115 North America Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 116 U.S. Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 117 Canada Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 118 Europe Recombinant Proteins Market Attractiveness Index
Figure 119 Europe Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 120 Europe Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 121 Europe Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 122 Europe Recombinant Proteins Market Forecast by Product and Services, 2023-2033 (US$ Million)
Figure 123 Europe Recombinant Proteins Market Share Forecast by Product and Services, 2023 & 2033 (%)
Figure 124 Europe Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 125 Europe Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 126 Europe Recombinant Proteins Market Forecast by Cytokines & Growth Factors, 2023-2033 (US$ Million)
Figure 127 Europe Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors, 2023 & 2033 (%)
Figure 128 Europe Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 129 Europe Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 130 Europe Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 131 Europe Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 132 Europe Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 133 Europe Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 134 Europe Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million)
Figure 135 Europe Recombinant Proteins Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 136 Europe Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 137 Europe Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 138 Germany Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 UK Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 140 France Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 141 Italy Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 142 Spain Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 Russia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 144 Rest of Europe Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 Asia Pacific Recombinant Proteins Market Attractiveness Index
Figure 146 Asia Pacific Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 147 Asia Pacific Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 148 Asia Pacific Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 149 Asia Pacific Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million)
Figure 150 Asia Pacific Recombinant Proteins Market Share Forecast by Product & Services, 2023 & 2033 (%)
Figure 151 Asia Pacific Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 152 Asia Pacific Recombinant Proteins Market Share Forecast by product type, 2023 & 2033 (%)
Figure 153 Asia Pacific Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million)
Figure 154 Asia Pacific Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors Type, 2023 & 2033 (%)
Figure 155 Asia Pacific Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 156 Asia Pacific Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 157 Asia Pacific Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 158 Asia Pacific Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 159 Asia Pacific Recombinant Proteins Market Forecast by Biopharmaceuticals Production, 2023-2033 (US$ Million)
Figure 160 Asia Pacific Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production, 2023 & 2033 (%)
Figure 161 Asia Pacific Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 162 Asia Pacific Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 163 Asia Pacific Recombinant Proteins Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 164 Asia Pacific Recombinant Proteins Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 165 Japan Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 166 China Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 167 India Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 168 Australia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 169 South Korea Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 170 Rest of Asia Pacific Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 171 Latin America Recombinant Proteins Market Attractiveness Index
Figure 172 Latin America Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 173 Latin America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 174 Latin America Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 175 Latin America Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million)
Figure 176 Latin America Recombinant Proteins Market Share Forecast by Product & Services, 2023 & 2033 (%)
Figure 177 Latin America Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 178 Latin America Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 179 Latin America Recombinant Proteins Market Forecast by Cytokines & Growth Factors, 2023-2033 (US$ Million)
Figure 180 Latin America Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors, 2023 & 2033 (%)
Figure 181 Latin America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 182 Latin America Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 183 Latin America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 184 Latin America Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 185 Latin America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 186 Latin America Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 187 Latin America Recombinant Proteins Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 188 Latin America Recombinant Proteins Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 189 Latin America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 190 Latin America Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 191 Brazil Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 192 Mexico Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 193 Argentina Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 194 Rest of Latin America Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 195 MEA Recombinant Proteins Market Attractiveness Index
Figure 196 MEA Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 197 MEA Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 198 MEA Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 199 MEA Recombinant Proteins Market Forecast by products & services , 2023-2033 (US$ Million)
Figure 200 MEA Recombinant Proteins Market Share Forecast by products & services, 2023 & 2033 (%)
Figure 201 MEA Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 202 MEA Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 203 MEA Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million)
Figure 204 MEA Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors Type, 2023 & 2033 (%)
Figure 205 MEA Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 206 MEA Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 207 MEA Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 208 MEA Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 209 MEA Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 210 MEA Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 211 MEA Recombinant Proteins Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 212 MEA Recombinant Proteins Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 213 MEA Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 214 MEA Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 215 GCC Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 216 South Africa Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 217 Rest of MEA Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 218 Recombinant Proteins Market: Company Share/Ranking, 2022
Figure 219 Abcam plc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 220 Abcam plc: Regional Market Shares, 2022
Figure 221 Bio-Techne.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 222 Bio-Techne.: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 223 Bio-Techne.: Regional Market Shares, 2022
Figure 224 Bio-Techne.: Segmental Market Shares, 2022
Figure 225 GenScript: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 226 GenScript: Regional Market Shares, 2022
Figure 227 GenScript: Segmental Market Shares, 2021
Figure 228 Bio-Rad Laboratories, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 229 Bio-Rad Laboratories, Inc.: Regional Market Shares, 202
Figure 230 Bio-Rad Laboratories, Inc.: Segmental Market Shares, 2022
Figure 231 Merck KGaA: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 232 Merck KGaA: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 233 Merck KGaA: Regional Market Shares, 2022
Figure 234 Merck KGaA: Segmental Market Shares, 2022
Figure 235 Thermo Fisher Scientific: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 236 Thermo Fisher Scientific: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 237 Thermo Fisher Scientific: Regional Market Shares, 2022
Figure 238 Thermo Fisher Scientific: Segmental Market Shares, 2022
Figure 239 Enzo Biochem Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 240 Enzo Biochem Inc.: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 241 Enzo Biochem Inc.: Regional Market Shares, 2022
Figure 242 Enzo Biochem Inc.: Segmental Market Shares, 2022
Figure 243 PerkinElmer Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 244 PerkinElmer Inc.: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 245 PerkinElmer Inc.: Regional Market Shares, 2022
Figure 246 PerkinElmer Inc.: Segmental Market Shares, 2022
Figure 247 Avantor Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 248 Avantor Inc.: Regional Market Shares, 2022

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Report Details

The Recombinant Proteins Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The rising prevalence and incidence of chronic illnesses, technological innovation, and expanding R&D investments by key companies are the primary drivers driving the growth of the recombinant proteins market. Increased awareness of chronic illnesses among the general public and governments is predicted to improve the market for recombinant goods. According to the World Health Organisation (WHO), chronic illnesses are the leading cause of mortality worldwide, accounting for over 60% of all fatalities.

The increased frequency of chronic illnesses is one of the major factors impacting the market. Diabetes, cancer, respiratory disorders, and cardiovascular disease are only a handful of the most common chronic diseases. According to Globocan forecasts, the number of cancer cases would rise from 19.3 million in 2020 to 24.6 million in 2030. Furthermore, by 2030, there will be 587 million diabetics globally. Chronic illnesses account for over 80% of mortality in middle- and low-income countries. Chronic illnesses are expected to affect more than 49% of the population in the U.S. by 2025. Strokes and heart problems account for 30% of all fatalities in the U.S.

What Questions Should You Ask before Buying a Market Research Report?
• How is the recombinant proteins market evolving?
• What is driving and restraining the recombinant proteins market?
• How will each recombinant proteins submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each recombinant proteins submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading recombinant proteins markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the recombinant proteins projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of recombinant proteins projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the recombinant proteins market?
• Where is the recombinant proteins market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the recombinant proteins market today, and over the next 10 years:
• Our 353-page report provides 146 tables and 248 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the recombinant proteins market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising recombinant proteins prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product & Services Outlook
• Products
– Cytokines & Growth Factors: Interferons (IFNs), Interleukins (ILs), Others
– Antibodies
– Enzymes: Kinases Enzymes, Metabolic Enzymes, Others
– Recombinant Regulatory Protein
– Hormones
– Virus Antigens
– Immune Checkpoint Proteins
– Others
• Services

Application Outlook
• Biopharmaceutical Production
– Biologics
– Vaccines
– Cell & Gene Therapies
– Others
• Drug Discovery & Development
• Research
• Diagnostics
• Others

Host Cell Outlook
• Mammalian Systems
• Bacterial Cells
• Yeast & Fungi
• Insect Cells
• Others

End-user Outlook
• Biopharmaceutical and Biotechnology Companies
• CROs
• Academic & Research Institutes
• Diagnostic Laboratories
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Recombinant Proteins Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abcam Plc
• Abnova Corporation
• Avantor Inc.
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Enzo Biochem Inc.
• GenScript
• Merck KGaA
• PerkinElmer, Inc.
• Proteintech Group, Inc.
• RayBiotech Life, Inc.
• Sino Biological Inc.
• STEMCELL Technologies
• Thermo Fisher Scientific Inc.

Overall world revenue for Recombinant Proteins Market, 2023 to 2033 in terms of value the market will surpass US$3,079.9 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Recombinant Proteins Market, 2023 to 2033 report help you?
In summary, our 350+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Recombinant Proteins Market, 2023 to 2033 Market, with forecasts for product & services, application, host cell, end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 22 key national markets – See forecasts for the Recombinant Proteins Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 14 of the major companies involved in the Recombinant Proteins Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Recombinant Proteins Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Recombinant Proteins Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Demand for Recombinant Products
3.2.1.2 High Funding for Biomedical Research
3.2.1.3 Increase in Number of Elderly Population will Drive the Market Growth
3.2.1.4 Patent Expiration for Biologics
3.2.2 Market Restraining Factors
3.2.2.1 Price Erosion of Recombinant Proteins
3.2.2.2 Stringent Regulation for Recombinant Proteins Production
3.2.3 Market Opportunities
3.2.3.1 Emerging Economies Expansion and Prioritisation of R&D
3.2.3.2 Growing Significance of Genomics and Proteomics
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors Impacting Recombinant Proteins Market
3.5.2 Economic Factors Impacting Recombinant Proteins Market
3.5.3 Social Factors Impacting Recombinant Proteins Market
3.5.4 Technological Factors Impacting Recombinant Proteins Market

4 Recombinant Proteins Market Analysis by Product & Services
4.1 Key Findings
4.2 Product & Services Segment: Market Attractiveness Index
4.3 Recombinant Proteins Market Size Estimation and Forecast by Product & Services
4.4 Products
4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Cytokines & Growth Factors
4.4.3.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.3.3 Interferons (IFNs)
4.4.3.4 Interleukins (ILs)
4.4.3.5 Others
4.4.4 Antibodies
4.4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.5 Enzymes
4.4.5.1 Enzymes Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.5.2 Market Share by Region, 2023 & 2033 (%)
4.4.5.3 Kinases enzymes
4.4.5.4 Metabolic enzymes
4.4.5.5 Other Enzymes
4.4.6 Recombinant Regulatory Protein
4.4.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.6.2 Market Share by Region, 2023 & 2033 (%)
4.4.7 Hormones
4.4.7.1 Hormones Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.7.2 Market Share by Region, 2023 & 2033 (%)
4.4.8 Virus Antigens
4.4.8.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.8.2 Market Share by Region, 2023 & 2033 (%)
4.4.9 Immune Checkpoint Proteins
4.4.9.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.9.2 Market Share by Region, 2023 & 2033 (%)
4.4.10 Others
4.4.10.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.4.10.2 Market Share by Region, 2023 & 2033 (%)
4.5 Services
4.5.1 Service Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Recombinant Proteins Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Recombinant Proteins Market Size Estimation and Forecast by Application
5.4 Biopharmaceutical Production
5.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.4.3 Biologics
5.4.3.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.3.2 Market Share by Region, 2023 & 2033 (%)
5.4.4 Vaccines
5.4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.4.2 Market Share by Region, 2023 & 2033 (%)
5.4.5 Cell & Gene Therapy
5.4.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.5.2 Market Share by Region, 2023 & 2033 (%)
5.4.6 Others
5.4.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.4.6.2 Market Share by Region, 2023 & 2033 (%)
5.5 Drug Discovery & Development
5.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Research
5.6.1 Research Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Diagnostics
5.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Others
5.8.1 Others Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
5.8.2 Market Share by Region, 2023 & 2033 (%)

6 Recombinant Proteins Market Analysis by Host Cell
6.1 Key Findings
6.2 Host Cell Segment: Market Attractiveness Index
6.3 Recombinant Proteins Market Size Estimation and Forecast by Host Cell
6.4 Mammalian Systems
6.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Bacterial Cells
6.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Yeast & Fungi
6.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Insect Cells
6.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Others
6.8.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
6.8.2 Market Share by Region, 2023 & 2033 (%)

7 Recombinant Proteins Market Analysis by End-User
7.1 Key Findings
7.2 Recombinant Proteins Market Size Estimation and Forecast by End-User
7.3 Biopharmaceutical and Biotechnology Companies
7.3.1 Biopharmaceutical and Biotechnology Companies Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.3.2 Market Share by Region, 2023 & 2033 (%)
7.4 CROs
7.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Academic & Research Institutes
7.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Diagnostic Laboratories
7.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Others
7.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
7.7.2 Market Share by Region, 2023 & 2033 (%)

8 Recombinant Proteins Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Recombinant Proteins Market Analysis
9.1 Key Findings
9.2 North America Recombinant Proteins Market Attractiveness Index
9.3 North America Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 North America Recombinant Proteins Market Size Estimation and Forecast by Country
9.5 North America Recombinant Proteins Market Size Estimation and Forecast by Product &Services
9.6 North America Recombinant Proteins Market Size Estimation and Forecast by Product Type
9.7 North America Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
9.8 North America Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
9.9 North America Recombinant Proteins Market Size Estimation and Forecast by Application
9.10 North America Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
9.11 North America Recombinant Proteins Market Size Estimation and Forecast by End-User
9.12 North America Recombinant Proteins Market Size Estimation and Forecast by Host Cell
9.13 U.S. Recombinant Proteins Market Analysis
9.14 Canada Recombinant Proteins Market Analysis

10 Europe Recombinant Proteins Market Analysis
10.1 Key Findings
10.2 Europe Recombinant Proteins Market Attractiveness Index
10.3 Europe Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Europe Recombinant Proteins Market Size Estimation and Forecast by Country
10.5 Europe Recombinant Proteins Market Size Estimation and Forecast by Product & Services
10.6 Europe Recombinant Proteins Market Size Estimation and Forecast by Product Type
10.7 Europe Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
10.8 Europe Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
10.9 Europe Recombinant Proteins Market Size Estimation and Forecast by Application
10.10 Europe Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
10.11 Europe Recombinant Proteins Market Size Estimation and Forecast by End-User
10.12 Europe Recombinant Proteins Market Size Estimation and Forecast by Host Cell
10.13 Germany Recombinant Proteins Market Analysis
10.14 UK Recombinant Proteins Market Analysis
10.15 France Recombinant Proteins Market Analysis
10.16 Italy Recombinant Proteins Market Analysis
10.17 Spain Recombinant Proteins Market Analysis
10.18 Russia Recombinant Proteins Market Analysis
10.19 Rest of Europe Recombinant Proteins Market Analysis

11 Asia Pacific Recombinant Proteins Market Analysis
11.1 Key Findings
11.2 Asia Pacific Recombinant Proteins Market Attractiveness Index
11.3 Asia Pacific Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Country
11.5 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Product & services
11.6 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Product Type
11.7 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
11.8 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
11.9 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Application
11.10 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
11.11 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Host Cell
11.12 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by End-User
11.13 Japan Recombinant Proteins Market Analysis
11.14 China Recombinant Proteins Market Analysis
11.15 India Recombinant Proteins Market Analysis
11.16 Australia Recombinant Proteins Market Analysis
11.17 South Korea Recombinant Proteins Market Analysis
11.18 Rest of Asia Pacific Recombinant Proteins Market Analysis

12 Latin America Recombinant Proteins Market Analysis
12.1 Key Findings
12.2 Latin America Recombinant Proteins Market Attractiveness Index
12.3 Latin America Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Latin America Recombinant Proteins Market Size Estimation and Forecast by Product & Services
12.5 Latin America Recombinant Proteins Market Size Estimation and Forecast by Product Type
12.6 Latin America Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
12.7 Latin America Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
12.8 Latin America Recombinant Proteins Market Size Estimation and Forecast by Application
12.9 Latin America Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
12.10 Latin America Recombinant Proteins Market Size Estimation and Forecast by End-User
12.11 Latin America Recombinant Proteins Market Size Estimation and Forecast by Host Cell
12.12 Brazil Recombinant Proteins Market Analysis
12.13 Mexico Recombinant Proteins Market Analysis
12.14 Argentina Recombinant Proteins Market Analysis
12.15 Rest of Latin America Recombinant Proteins Market Analysis

13 MEA Recombinant Proteins Market Analysis
13.1 Key Findings
13.2 MEA Recombinant Proteins Market Attractiveness Index
13.3 MEA Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 MEA Recombinant Proteins Market Size Estimation and Forecast by Country
13.5 MEA Recombinant Proteins Market Size Estimation and Forecast by Product & Services
13.6 MEA Recombinant Proteins Market Size Estimation and Forecast by Product Type
13.7 MEA Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
13.8 MEA Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
13.9 MEA Recombinant Proteins Market Size Estimation and Forecast by Application
13.10 MEA Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
13.11 MEA Recombinant Proteins Market Size Estimation and Forecast by End-users
13.12 MEA Recombinant Proteins Market Size Estimation and Forecast by End-users
13.13 GCC Recombinant Proteins Market Analysis
13.14 South Africa Recombinant Proteins Market Analysis
13.15 Rest of MEA Recombinant Proteins Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Abcam plc
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2017-2022
14.2.3.2 Regional Market Shares, 2022
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Bio-Techne
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2022
14.3.3.2 Research & Development, 2017-2022
14.3.3.3 Regional Market Shares, 2022
14.3.3.4 Segmental Market Shares, 2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 GenScript
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2022
14.4.3.2 Regional Market Shares, 2022
14.4.3.3 Segmental Market Shares, 2021
14.4.4 Product Benchmarking
14.5 Bio-Rad Laboratories, Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2022
14.5.3.2 Regional Market Shares, 2022
14.5.3.3 Segmental Market Shares, 2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Merck KGaA
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2022
14.6.3.2 Research & Development, 2017-2022
14.6.3.3 Regional Market Shares, 2022
14.6.3.4 Segmental Market Shares, 2022
14.6.4 Product Benchmarking
14.7 Thermo Fisher Scientific
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2017-2022
14.7.3.2 Research and Development, 2017-2022
14.7.3.3 Regional Market Shares, 2022
14.7.3.4 Segmental Market Shares, 2022
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Enzo Biochem Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2022
14.8.3.2 Research & Development, 2017-2022
14.8.3.3 Regional Market Shares, 2022
14.8.3.4 Segmental Market Shares, 2022
14.8.4 Product Benchmarking
14.9 Sino Biological, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.10 Proteintech Group, Inc
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.11 Abnova Corporation
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.12 RayBiotech Life, Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.13 STEMCELL Technologies
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 PerkinElmer Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2017-2022
14.14.3.2 Research & Development, 2017-2022
14.14.3.3 Regional Market Shares, 2022
14.14.3.4 Segmental Market Shares, 2022
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 Avantor Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2017-2022
14.15.3.2 Regional Market Shares, 2022
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 Recombinant Proteins Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Product Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Cytokines & Growth Factors Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Interferons (IFNs)Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Interleukins (ILs) Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Antibodies Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Kinases Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Metabolic Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Other Enzymes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Recombinant Regulatory Protein Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Hormones Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Virus Antigens Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Immune Checkpoint Proteins Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Service Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Biopharmaceutical production Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Biologics Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Cell & Gene Therapies Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Drug Discovery & Development Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Research Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Diagnostics Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Mammalian Systems Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Bacterial Cells Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Yeast & Fungi Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Insect Cells Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Biopharmaceutical and Biotechnology Companies Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 CROs Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Academic & Research Institutes Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Diagnostic Laboratories Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Others Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Recombinant Proteins Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 46 North America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 North America Recombinant Proteins Market Forecast by Product &Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 North America Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 North America Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 North America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 North America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 North America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 North America Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 North America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 U.S. Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Canada Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Europe Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Europe Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Europe Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Europe Recombinant Proteins Market Forecast by Cytokines & Growth Factors, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Europe Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Europe Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Europe Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Europe Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Europe Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Germany Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 UK Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 France Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 Italy Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 Spain Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 Russia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 Rest of Europe Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 Asia Pacific Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Asia Pacific Recombinant Proteins Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Asia Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 Asia Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 Asia Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 78 Asia Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 79 Asia-Pacific Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 80 Asia Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 81 Asia Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 82 Japan Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 83 China Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 84 India Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 85 Australia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 86 South Korea Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 87 Rest of Asia Pacific Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 88 Latin America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 89 Latin America Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 90 MEA Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 91 Latin America Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 92 Latin America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 93 Latin America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 94 Latin America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 95 Latin America Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 96 Latin America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 97 Brazil Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 98 Mexico Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 99 Argentina Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 100 Rest of Latin America Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 101 MEA Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 102 MEA Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 103 MEA Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 104 MEA Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 105 MEA Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 106 MEA Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 107 MEA Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 108 MEA Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 109 MEA Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 110 GCC Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 111 South Africa Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 112 Rest of MEA Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 113 Abcam plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Abcam plc: Product Benchmarking
Table 115 Abcam plc: Strategic Outlook
Table 116 Bio-Techne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Bio-Techne.: Product Benchmarking
Table 118 Bio-Techne.: Strategic Outlook
Table 119 GenScript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 GenScript: Product Benchmarking
Table 121 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Bio-Rad Laboratories, Inc.: Product Benchmarking
Table 123 Bio-Rad Laboratories, Inc.: Strategic Outlook
Table 124 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Merck KGaA: Product Benchmarking
Table 126 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Thermo Fisher Scientific: Product Benchmarking
Table 128 Thermo Fisher Scientific: Strategic Outlook
Table 129 Enzo Biochem Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Enzo Biochem Inc.: Product Benchmarking
Table 131 Sino Biological, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Sino Biological, Inc.: Product Benchmarking
Table 133 Proteintech Group, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Proteintech Group, Inc: Product Benchmarking
Table 135 Abnova Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Abnova Corporation: Product Benchmarking
Table 137 RayBiotech Life, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 RayBiotech Life, Inc.: Product Benchmarking
Table 139 STEMCELL Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 STEMCELL Technologies: Product Benchmarking
Table 141 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 PerkinElmer Inc.: Product Benchmarking
Table 143 PerkinElmer Inc.: Strategic Outlook
Table 144 Avantor Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 Avantor Inc.: Product Benchmarking
Table 146 Avantor Inc.: Strategic Outlook

List of Figures
Figure 1 Recombinant Proteins Market Segmentation
Figure 2 Recombinant Proteins Market by Products: Market Attractiveness Index
Figure 3 Recombinant Proteins Market Attractiveness Index by Region
Figure 4 Recombinant Proteins Market: Market Dynamics
Figure 5 NIH Program Level Budget
Figure 6 Global Population Aged 65+, 2022 (Unit Million)
Figure 7 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Recombinant Proteins Market: Porter’s Five Forces Analysis
Figure 12 Recombinant Proteins Market: PEST Analysis
Figure 13 Recombinant Proteins Market Forecast by Product & Services Market Attractiveness Index
Figure 14 Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million)
Figure 15 Recombinant Proteins Market Share Forecast by Product & Services, 2023, 2028, 2033 (%)
Figure 16 Product Market Forecast by Region, 2022-2033 (US$ Million)
Figure 17 Product Market Share Forecast by Region, 2023 & 2033 (%)
Figure 18 Cytokines & Growth Factors Market Forecast by Region, 2023-2033 (US$ Million)
Figure 19 Cytokines & Growth Factors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Interferons (IFNs) Market Forecast by Region, 2023-2033 (US$ Million)
Figure 21 Interferons (IFNs) Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 interleukins (ILs)Market Forecast by Region, 2023-2033 (US$ Million)
Figure 23 interleukins (ILs)Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 25 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Antibodies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 27 Antibodies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Enzymes Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Enzymes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Kinase Enzyme Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Kinase Enzyme Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Metabolic Enzyme Market Forecast by Region, 2023-2033 (US$ Million)
Figure 33 Metabolic Enzyme Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Other Enzyme Market Forecast by Region, 2023-2033 (US$ Million)
Figure 35 Other Enzyme Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Recombinant Regulatory Protein Market Forecast by Region, 2023-2033 (US$ Million)
Figure 37 Recombinant Regulatory Protein Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Hormones Market Forecast by Region, 2023-2033 (US$ Million)
Figure 39 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Virus Antigens Market Forecast by Region, 2023-2033 (US$ Million)
Figure 41 Virus Antigens Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Immune Checkpoint Proteins Market Forecast by Region, 2023-2033 (US$ Million)
Figure 43 Immune Checkpoint Proteins Market Share Forecast by Region, 2023 & 2033 (%)
Figure 44 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 45 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 46 Services Market Forecast by Region, 2023-2033 (US$ Million)
Figure 47 Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 48 Recombinant Proteins Market Forecast by Application 2023, 2028, 2033 (Revenue, CAGR%)
Figure 49 Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 50 Recombinant Proteins Market Share Forecast by Application 2023, 2028, 2033 (%)
Figure 51 Biopharmaceutical Production Market Forecast by Region, 2023-2033 (US$ Million)
Figure 52 Biopharmaceutical production Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Biologics Market Forecast by Region, 2023-2033 (US$ Million)
Figure 54 Biologics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 55 Vaccines Market Forecast by Region, 2023-2033 (US$ Million)
Figure 56 Vaccines Market Share Forecast by Region, 2023 & 2033 (%)
Figure 57 Cell & Gene Therapy Market Forecast by Region, 2023-2033 (US$ Million)
Figure 58 Cell & Gene Therapy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 59 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 60 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 61 Drug Discovery & Development Market Forecast by Region, 2023-2033 (US$ Million)
Figure 62 Drug Discovery & Development Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 Research Market Forecast by Region, 2023-2033 (US$ Million)
Figure 64 Research Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Diagnostics Market Forecast by Region, 2023-2033 (US$ Million)
Figure 66 Diagnostics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 68 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 69 Recombinant Proteins Market Forecast by Host Cell 2023, 2028, 2033 (Revenue, CAGR%)
Figure 70 Recombinant Proteins Market Forecast by Host Cells, 2023-2033 (US$ Million)
Figure 71 Recombinant Proteins Market Share Forecast by Host Cells, 2023, 2028, 2033 (%)
Figure 72 Mammalian System Market Forecast by Region, 2023-2033 (US$ Million)
Figure 73 Mammalian System Market Share Forecast by Region, 2023 & 2033 (%)
Figure 74 Bacterial Cells Market Forecast by Region, 2023-2033 (US$ Million)
Figure 75 Bacterial Cells Market Share Forecast by Region, 2023 & 2033 (%)
Figure 76 Yeast and Fungi Market Forecast by Region, 2023-2033 (US$ Million)
Figure 77 Yeast & Fungi Market Share Forecast by Region, 2023 & 2033 (%)
Figure 78 Insect Cells Market Forecast by Region, 2023-2033 (US$ Million)
Figure 79 Insect Cells Market Share Forecast by Region, 2023 & 2033 (%)
Figure 80 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 81 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 82 Recombinant Proteins Market Forecast by Therapeutics, 2023-2033 (US$ Million)
Figure 83 Recombinant Proteins Market Share Forecast by Therapeutics, 2023, 2028, 2033 (%)
Figure 84 Biopharmaceutical and Biotechnology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 85 Biopharmaceutical and Biotechnology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 86 CROs Market Forecast by Region, 2023-2033 (US$ Million)
Figure 87 CROs Market Share Forecast by Region, 2023 & 2033 (%)
Figure 88 Research Market Forecast by Region, 2023-2033 (US$ Million)
Figure 89 Academic & Research Institutes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 90 Diagnostics Laboratories Market Forecast by Region, 2023-2033 (US$ Million)
Figure 91 Diagnostics Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
Figure 92 Others Market Forecast by Region, 2023-2033 (US$ Million)
Figure 93 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 94 Recombinant Proteins Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 95 Recombinant Proteins Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Figure 96 North America Recombinant Proteins Market Attractiveness Index
Figure 97 North America Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 98 North America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 99 North America Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 100 North America Recombinant Proteins Market Forecast by Products and Services, 2023-2033 (US$ Million)
Figure 101 North America Recombinant Proteins Market Share Forecast by Products and Services, 2023 & 2033 (%)
Figure 102 North America Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 103 North America Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 104 North America Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million)
Figure 105 North America Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors Type, 2023 & 2033 (%)
Figure 106 North America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 107 North America Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 108 North America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 109 North America Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 110 North America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 111 North America Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 112 North America Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million)
Figure 113 North America Recombinant Proteins Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 114 North America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 115 North America Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 116 U.S. Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 117 Canada Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 118 Europe Recombinant Proteins Market Attractiveness Index
Figure 119 Europe Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 120 Europe Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 121 Europe Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 122 Europe Recombinant Proteins Market Forecast by Product and Services, 2023-2033 (US$ Million)
Figure 123 Europe Recombinant Proteins Market Share Forecast by Product and Services, 2023 & 2033 (%)
Figure 124 Europe Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 125 Europe Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 126 Europe Recombinant Proteins Market Forecast by Cytokines & Growth Factors, 2023-2033 (US$ Million)
Figure 127 Europe Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors, 2023 & 2033 (%)
Figure 128 Europe Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 129 Europe Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 130 Europe Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 131 Europe Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 132 Europe Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 133 Europe Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 134 Europe Recombinant Proteins Market Forecast by End-User, 2023-2033 (US$ Million)
Figure 135 Europe Recombinant Proteins Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 136 Europe Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 137 Europe Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 138 Germany Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 UK Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 140 France Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 141 Italy Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 142 Spain Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 Russia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 144 Rest of Europe Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 Asia Pacific Recombinant Proteins Market Attractiveness Index
Figure 146 Asia Pacific Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 147 Asia Pacific Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 148 Asia Pacific Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 149 Asia Pacific Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million)
Figure 150 Asia Pacific Recombinant Proteins Market Share Forecast by Product & Services, 2023 & 2033 (%)
Figure 151 Asia Pacific Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 152 Asia Pacific Recombinant Proteins Market Share Forecast by product type, 2023 & 2033 (%)
Figure 153 Asia Pacific Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million)
Figure 154 Asia Pacific Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors Type, 2023 & 2033 (%)
Figure 155 Asia Pacific Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 156 Asia Pacific Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 157 Asia Pacific Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 158 Asia Pacific Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 159 Asia Pacific Recombinant Proteins Market Forecast by Biopharmaceuticals Production, 2023-2033 (US$ Million)
Figure 160 Asia Pacific Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production, 2023 & 2033 (%)
Figure 161 Asia Pacific Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 162 Asia Pacific Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 163 Asia Pacific Recombinant Proteins Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 164 Asia Pacific Recombinant Proteins Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 165 Japan Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 166 China Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 167 India Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 168 Australia Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 169 South Korea Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 170 Rest of Asia Pacific Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 171 Latin America Recombinant Proteins Market Attractiveness Index
Figure 172 Latin America Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 173 Latin America Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 174 Latin America Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 175 Latin America Recombinant Proteins Market Forecast by Product & Services, 2023-2033 (US$ Million)
Figure 176 Latin America Recombinant Proteins Market Share Forecast by Product & Services, 2023 & 2033 (%)
Figure 177 Latin America Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 178 Latin America Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 179 Latin America Recombinant Proteins Market Forecast by Cytokines & Growth Factors, 2023-2033 (US$ Million)
Figure 180 Latin America Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors, 2023 & 2033 (%)
Figure 181 Latin America Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 182 Latin America Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 183 Latin America Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 184 Latin America Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 185 Latin America Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 186 Latin America Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 187 Latin America Recombinant Proteins Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 188 Latin America Recombinant Proteins Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 189 Latin America Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 190 Latin America Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 191 Brazil Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 192 Mexico Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 193 Argentina Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 194 Rest of Latin America Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 195 MEA Recombinant Proteins Market Attractiveness Index
Figure 196 MEA Recombinant Proteins Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 197 MEA Recombinant Proteins Market Forecast by Country, 2023-2033 (US$ Million)
Figure 198 MEA Recombinant Proteins Market Share Forecast by Country, 2023 & 2033 (%)
Figure 199 MEA Recombinant Proteins Market Forecast by products & services , 2023-2033 (US$ Million)
Figure 200 MEA Recombinant Proteins Market Share Forecast by products & services, 2023 & 2033 (%)
Figure 201 MEA Recombinant Proteins Market Forecast by Product Type, 2023-2033 (US$ Million)
Figure 202 MEA Recombinant Proteins Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 203 MEA Recombinant Proteins Market Forecast by Cytokines & Growth Factors Type, 2023-2033 (US$ Million)
Figure 204 MEA Recombinant Proteins Market Share Forecast by Cytokines & Growth Factors Type, 2023 & 2033 (%)
Figure 205 MEA Recombinant Proteins Market Forecast by Enzymes Type, 2023-2033 (US$ Million)
Figure 206 MEA Recombinant Proteins Market Share Forecast by Enzymes Type, 2023 & 2033 (%)
Figure 207 MEA Recombinant Proteins Market Forecast by Application, 2023-2033 (US$ Million)
Figure 208 MEA Recombinant Proteins Market Share Forecast by Application, 2023 & 2033 (%)
Figure 209 MEA Recombinant Proteins Market Forecast by Biopharmaceuticals Production Type, 2023-2033 (US$ Million)
Figure 210 MEA Recombinant Proteins Market Share Forecast by Biopharmaceuticals Production Type, 2023 & 2033 (%)
Figure 211 MEA Recombinant Proteins Market Forecast by End-users, 2023-2033 (US$ Million)
Figure 212 MEA Recombinant Proteins Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 213 MEA Recombinant Proteins Market Forecast by Host Cell, 2023-2033 (US$ Million)
Figure 214 MEA Recombinant Proteins Market Share Forecast by Host Cell, 2023 & 2033 (%)
Figure 215 GCC Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 216 South Africa Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 217 Rest of MEA Recombinant Proteins Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 218 Recombinant Proteins Market: Company Share/Ranking, 2022
Figure 219 Abcam plc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 220 Abcam plc: Regional Market Shares, 2022
Figure 221 Bio-Techne.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 222 Bio-Techne.: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 223 Bio-Techne.: Regional Market Shares, 2022
Figure 224 Bio-Techne.: Segmental Market Shares, 2022
Figure 225 GenScript: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 226 GenScript: Regional Market Shares, 2022
Figure 227 GenScript: Segmental Market Shares, 2021
Figure 228 Bio-Rad Laboratories, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 229 Bio-Rad Laboratories, Inc.: Regional Market Shares, 202
Figure 230 Bio-Rad Laboratories, Inc.: Segmental Market Shares, 2022
Figure 231 Merck KGaA: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 232 Merck KGaA: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 233 Merck KGaA: Regional Market Shares, 2022
Figure 234 Merck KGaA: Segmental Market Shares, 2022
Figure 235 Thermo Fisher Scientific: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 236 Thermo Fisher Scientific: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 237 Thermo Fisher Scientific: Regional Market Shares, 2022
Figure 238 Thermo Fisher Scientific: Segmental Market Shares, 2022
Figure 239 Enzo Biochem Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 240 Enzo Biochem Inc.: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 241 Enzo Biochem Inc.: Regional Market Shares, 2022
Figure 242 Enzo Biochem Inc.: Segmental Market Shares, 2022
Figure 243 PerkinElmer Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 244 PerkinElmer Inc.: Research & Development, 2017-2022 (US$ Million, AGR%)
Figure 245 PerkinElmer Inc.: Regional Market Shares, 2022
Figure 246 PerkinElmer Inc.: Segmental Market Shares, 2022
Figure 247 Avantor Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 248 Avantor Inc.: Regional Market Shares, 2022

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（遺伝子解析）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（antibodies）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

組換えタンパク質市場レポート：2023-2033

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（遺伝子解析）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（antibodies）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?